Latent

Emerging

Healthcare AI automating prior authorization documentation by reviewing patient records; $13.1M from General Catalyst and YC achieving $2.4M revenue competing with Cohere Health for pharmacy workflow automation.

Company Overview

About Latent

Latent is a San Francisco-based healthcare AI company automating clinical operations for pharmacy and medication access workflows — using AI to review patient medical records, generate evidence-based prior authorization documentation, and streamline the clinical justification process that currently requires pharmacists and clinical staff to spend significant time on administrative documentation that delays patients' access to medications. Founded in 2022 and a Y Combinator W23 graduate, Latent raised $13.1 million from General Catalyst and Y Combinator, achieving $2.4 million in revenue in 2024.

Business Model & Competitive Advantage

Latent's AI reads patient clinical records (diagnoses, labs, prior medication history, physician notes) and generates the clinical evidence summaries and prior authorization submissions that insurance companies require before approving specialty medications. Prior authorization — the process where physicians must justify to insurance companies why a specific (often expensive) medication is medically necessary — has become one of the most administratively burdensome aspects of healthcare, with studies showing physicians spend 2+ hours per day on prior auth requests for their patient panels.

Competitive Landscape 2025–2026

In 2025, Latent competes in the prior authorization automation and healthcare AI market with Cohere Health (prior auth automation, raised $150M+), Waystar (revenue cycle, acquired Olive AI's prior auth business), Availity, and physician practice management platforms for prior authorization and clinical documentation automation. The AMA's annual survey consistently shows prior authorization as physicians' top administrative burden, and multiple legislative efforts (including CMS prior authorization rules taking effect in 2026) are attempting to streamline the process. AI automation that handles the record review and documentation generation can reduce this burden while actually improving approval rates — AI systems that correctly identify and present clinical evidence get approvals that manual submissions miss. General Catalyst's backing is strategically significant in healthcare AI. The 2025 strategy focuses on pharmacy benefit management integration, specialty medication focus (oncology, biologics) where prior auth burden is highest, and health system enterprise deployments.

Revenue
$13.1M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Latent is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

AbbVie

Healthcare
AnalyticsB2bEnterpriseGlobalHealthtechPublic

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp

Chick-fil-A

Consumer Food & Beverage
B2cServicesNorth AmericaEnterprise

Chick-fil-A is the largest US quick-service chicken restaurant chain, generating over $22 billion in annual system-wide sales from approximately 3,000 locations — more revenue per restaurant than any

Yoneda Labs

Healthcare
HealthtechB2bNorth America

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit

Decoda Health

Healthcare
HealthtechAi PoweredAutomationNorth America

Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Compare Latent with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Latent

Claim This Profile

Are you from Latent? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Latent Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Latent vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →